Concentra reports preliminary Q4 adjusted EPS 28c, consensus 23c

Reports preliminary Q4 revenue $539.1M, consensus $532M. “The 2025 fiscal year was another transformative year for Concentra (CON) as we continued to provide superior outcomes and exceptional experience to our patients and customers, all while significantly growing our business,” said Keith Newton, Concentra’s Chief Executive Officer. “Our excellent performance in 2025 is a testament to our skilled and dedicated colleagues’ efforts to improve the health of America’s workforce, one patient at a time.”